FDA approves drug Sotyktu for treatment of plaque psoriasis
The FDA has approved a new oral treatment, Sotyktu (deucravacitinib) for plaque psoriasis, a chronic skin condition. In clinical trials, the new drug was more effective than the current most popular oral drug for the...
Read More